Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Victoria

$36,000.00

Research Program in Structural Proteomics to Characterize Misfolded Proteins

EF 2019-20

Résumé
Prion diseases are rare, fatal, degenerative brain disorders that are thought to occur worldwide in both humans and animals. They belong to the general category of brain diseases called proteinopathies, which also includes Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis (ALS). Although there are several forms of human prion disease, the most common is Creutzfeldt-Jakob disease (CJD). Prion diseases of animals include Bovine Spongiform Encephalopathy (BSE) in cattle, Scrapie in sheep and goats, and Chronic Wasting Disease (CWD) in deer and elk. These diseases have caused great public health concern because of their many difficult and unusual features.***Protein misfolding and aggregation is involved in many prions diseases. The study of these proteins' misfolding and aggregation, using mass spectrometry, is at the interface of biophysics, analytical chemistry, organic chemistry, and protein chemistry.******The overall objective of this research program is to further develop a set of comprehensive structural proteomics methods, and apply these methods to the characterization of protein misfolding and aggregation as it relates to neurodegenerative diseases. By determining the conformational changes that occur during the proteins' misfolding events, we anticipate being able to design structure-based reagents that will block both this misfolding and the resulting protein aggregation. The complementary data delivered by these various experimental approaches will provide a solid foundation for solving the structure of proteins and protein complexes, and for determining the details of the conformational changes and protein-protein interactions involved in neurodegenerative protein misfolding and aggregation. ***In addition, we propose to advance these structural proteomics approaches to the next level of complexity, by studying misfolding and aggregation of neurodegenerative proteins in their natural environment, i.e. in vivo. Our goal is to further advance, develop and integrate these various approaches for solving challenging protein structural problems in animal and human neurodegenerative diseases development. ******The program will provide insights on diseases that represent high economic burdens and will bring benefits to both the animal and human health sectors. For example, in 2003, a single case of BSE was confirmed in Canada and within the first year the ensuing losses to Canada exceeded $6 billion rising to greater than $10 billion by 2007.New cases of BSE have been identified in Scotland and the US in 2018. Moreover, the number of people living with Alzheimer's disease is expected to triple in the next 37 years. Proteins are of great interest in drug development as therapeutic targets. Once developed, these methods will be made publically available so that other researchers can apply them to problems in other diseases where misfolded proteins are now thought to play a part of (cancer and autoimmune diseases). **
Programme
Discovery Grants Program - Individual
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2019-04792
Name nom
Borchers, Christoph
Department département
Biochemistry and Microbiology
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3500
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical chemistry
Research subject fr
Chimie analytique
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Research Program in Structural Proteomics to Characterize Misfolded Proteins
Keyword
NSERC
Application summary
Prion diseases are rare, fatal, degenerative brain disorders that are thought to occur worldwide in both humans and animals. They belong to the general category of brain diseases called proteinopathies, which also includes Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis (ALS). Although there are several forms of human prion disease, the most common is Creutzfeldt-Jakob disease (CJD). Prion diseases of animals include Bovine Spongiform Encephalopathy (BSE) in cattle, Scrapie in sheep and goats, and Chronic Wasting Disease (CWD) in deer and elk. These diseases have caused great public health concern because of their many difficult and unusual features.***Protein misfolding and aggregation is involved in many prions diseases. The study of these proteins' misfolding and aggregation, using mass spectrometry, is at the interface of biophysics, analytical chemistry, organic chemistry, and protein chemistry.******The overall objective of this research program is to further develop a set of comprehensive structural proteomics methods, and apply these methods to the characterization of protein misfolding and aggregation as it relates to neurodegenerative diseases. By determining the conformational changes that occur during the proteins' misfolding events, we anticipate being able to design structure-based reagents that will block both this misfolding and the resulting protein aggregation. The complementary data delivered by these various experimental approaches will provide a solid foundation for solving the structure of proteins and protein complexes, and for determining the details of the conformational changes and protein-protein interactions involved in neurodegenerative protein misfolding and aggregation. ***In addition, we propose to advance these structural proteomics approaches to the next level of complexity, by studying misfolding and aggregation of neurodegenerative proteins in their natural environment, i.e. in vivo. Our goal is to further advance, develop and integrate these various approaches for solving challenging protein structural problems in animal and human neurodegenerative diseases development. ******The program will provide insights on diseases that represent high economic burdens and will bring benefits to both the animal and human health sectors. For example, in 2003, a single case of BSE was confirmed in Canada and within the first year the ensuing losses to Canada exceeded $6 billion rising to greater than $10 billion by 2007.New cases of BSE have been identified in Scotland and the US in 2018. Moreover, the number of people living with Alzheimer's disease is expected to triple in the next 37 years. Proteins are of great interest in drug development as therapeutic targets. Once developed, these methods will be made publically available so that other researchers can apply them to problems in other diseases where misfolded proteins are now thought to play a part of (cancer and autoimmune diseases). **